Ticker: LMT Exchange: L

Lombard Medical is focused on the development, manufacturing and commercialisation of innovative endovascular aortic repair (EVAR) devices such as abdominal and thoracic aortic aneurysms (AAA & TAC respectively). The lead product, 'Aorfix' for AAA is a synthetic aortic abdominal bifurcated stent-graft, marketed in Europe through direct sales in the UK and in Germany and through a network of local distributors supported by clinical specialists from Lombard Medical in the rest of Continental Europe. In the US 'Aorfix' is in the final stages of the regulatory approval, having filed five of the six Pre-Market Approval (PMA) filings and having received approval for the first three PMA modules. Aorfix has been designed to also address complex and tortuous aneurysmal or iliac anatomy including those with high-angle-neck angulations (up-to 90degrees), that are normally referred to open surgery as they are not currently covered by marketed devices, allowing Lombard Medical to cater for a larger number of aneurysms.

Latest Reports